Are e-signatures legally valid?

Yes. Electronic signatures that meet intent, consent, attribution, and record retention standards are legally enforceable under the ESIGN Act (15 U.S.C. §7001) and under UETA where adopted; certain exceptions such as wills and court filings remain ineligible.

How do I ensure HIPAA compliance?

Include explicit HIPAA authorization language, execute a Business Associate Agreement when a vendor will handle PHI, ensure encryption in transit and at rest (TLS 1.2/1.3, AES-256), and retain authorizations for six years per 45 CFR §164.530(j).

What level of signer authentication is sufficient?

Authentication depends on risk: email-only may suffice for low-risk approvals, while SMS, KBA, or multifactor authentication is recommended for PHI or regulated records. Stronger authentication improves attribution and auditability during disputes.

Is notarization required for CTAs?

Most CTAs do not require notarization, but institution policies or state law may require notarized signatures for specific exhibits or power-of-attorney documents. Use Remote Online Notarization where permitted and retain notarization records.

How do I amend an executed CTA?

Execute a written amendment that references the original agreement, have authorized signers sign and date the amendment, and retain it with the original CTA. Clearly state effective dates and any retroactive effects on reporting or payments.

How long should I keep signed CTAs?

Follow federal and industry retention rules: retain financial/tax records at least three years (IRC §6501(a)), HIPAA-related records six years (45 CFR §164.530(j)), and longer where state law or funder requirements apply.

Electronic Signature
Templates
Healthcare
Healthcare CTA Agreement

Healthcare CTA Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CTA AGREEMENT

Parties and Agreement Overview

This Clinical Trial Agreement (the Agreement) is entered into between Sponsor Name: and Site/Institution Name: for the conduct of the clinical investigation described below.

Protocol Title: Protocol Number:

Effective Date

Scope of Services

Site shall conduct the clinical investigation in accordance with the Protocol, Good Clinical Practice, applicable laws and regulations, and the terms set forth in this Agreement. Sponsor shall provide investigational product, study materials, and required training.

Detailed obligations of Site (summary)

Regulatory and Ethics Compliance

Site shall obtain Institutional Review Board/Ethics Committee approval prior to initiating study activities and shall maintain all study records necessary for regulatory compliance. Sponsor shall timely provide all required regulatory documentation, including investigational brochures and safety updates.

IRB/EC approval date

Subject Enrollment and Informed Consent

Site is responsible for obtaining informed consent from each subject prior to any study-specific procedures. Consent documents shall be approved by the IRB/EC and shall include information on risks, benefits, alternatives, and subject rights including the right to withdraw without penalty.

Person responsible for informed consent (name & title)

Compensation and Payment Terms

Sponsor agrees to compensate Site for performance of study-related activities according to the budget attached as Exhibit A. Payments are contingent upon receipt of proper invoice and required deliverables.

Total Maximum Compensation Payment schedule and invoicing requirements

Confidentiality, Data Use, and Publications

Each party shall keep confidential all proprietary information disclosed by the other and shall not use such information except to perform obligations under this Agreement. Investigator-authored publications shall be subject to Sponsor review for a limited period to protect confidential information and patent rights; Sponsor review shall not unreasonably delay publication.

Data ownership and post-trial use (summary)

Indemnification and Insurance

Sponsor shall indemnify and hold harmless Site, its investigators and personnel from claims arising from the use of the investigational product, to the extent caused by Sponsor's negligent acts or willful misconduct. Site shall maintain professional liability insurance covering investigational activities and shall provide certificates of insurance upon request.

Insurance carrier and policy number

HIPAA and Protected Health Information (PHI)

To the extent PHI is accessed or disclosed in connection with the Study, the parties shall comply with applicable privacy laws. Site shall obtain any required patient authorizations and shall de-identify data where feasible prior to transfer to Sponsor. Use of PHI by Sponsor is limited to purposes of study conduct and regulatory compliance.

HIPAA contact at Site (name, phone)

Audits, Records and Access

Sponsor or its designees shall have the right to audit Site records relevant to the study, subject to reasonable notice and confidentiality obligations. Site shall retain essential documents for the period required by applicable law and by Sponsor.

Record retention period (years)

Term, Termination and Effect of Termination

This Agreement shall commence on the Effective Date and continue until completion of the Study unless earlier terminated. Either party may terminate for cause upon written notice if the other party materially breaches and fails to cure within the notice period set forth below.

Termination notice period (days)

Governing Law and Dispute Resolution

This Agreement shall be governed by the laws of the state specified below without regard to conflict of laws principles. Parties shall attempt to resolve disputes in good faith and may pursue mediation prior to litigation.

Governing state

Representations, Warranties and Certifications

Each party represents and warrants that it has the authority to enter into this Agreement, that its performance will comply with applicable laws, and that it will not knowingly subject the other party to regulatory liability through the wrongful disclosure of information.

Attachments and Exhibits

The following Exhibits and attachments are incorporated into this Agreement and control in case of conflict: Exhibit A (Budget), Exhibit B (Protocol), Exhibit C (Invoice Instructions).

Exhibits attached (check applicable)

Exhibit A — Budget Exhibit B — Protocol Exhibit C — Invoice Instructions

Miscellaneous Provisions

Notices shall be in writing and delivered to the addresses below. No amendment shall be effective unless in writing and signed by authorized representatives of both parties. Severability: invalid provisions shall be severed without affecting the remainder of this Agreement.

Sponsor notice address Site notice address

Sponsor (Party Label):

By:

Date:

Site/Institution (Party Label):

By:

Date:

What the Healthcare CTA Agreement Is

The Healthcare CTA Agreement (Clinical Trial Agreement) is a legally binding contract that sets terms between a study sponsor, clinical site, and any third-party service providers for a clinical trial or investigational study. It defines responsibilities including study scope, protocol adherence, subject enrollment, data handling, payment and indemnification. The agreement addresses patient privacy, data ownership, publication rights, and regulatory obligations such as HIPAA and FDA recordkeeping (21 CFR Part 11) where applicable. Parties use the CTA to allocate risk, set timelines, and document compensation, ensuring a clear baseline for operational and compliance activities across the trial lifecycle.

Why a Clear CTA Agreement Matters

Standardizing a Healthcare CTA Agreement clarifies study roles, protects patient data under HIPAA, and reduces negotiation time. It sets payment and indemnity terms, supports regulatory compliance, and helps avoid billing disputes or delays that can jeopardize enrollment and study timelines.

Who Typically Completes and Signs a CTA

Typical organizations and roles that complete, review, or sign Healthcare CTA Agreements include research sponsors, investigative sites, and institutional legal teams.

Sponsors and CROs — manage protocol, budget, sponsor-side obligations, including payment schedules.
Investigative sites — PI and research staff handle enrollment, consent, and local compliance.
Institutional legal, finance, and IRB offices — review indemnity, data use, and liability.

Clear role definition improves approval speed and reduces downstream operational risk in study execution and supports audit readiness.

Primary Parties and Their Responsibilities

Sponsor / CRO

Sponsors and CROs negotiate CTA terms to secure study conduct, timelines, and payment. Their legal, clinical operations, and finance teams coordinate protocol obligations, safety reporting, and budget distributions. Accurate CTAs avoid reimbursement disputes and ensure sponsor responsibilities are enforceable.

Investigative Site

Investigative sites (hospitals, clinics) use CTAs to document investigator obligations, subject recruitment responsibilities, indemnification, and payment timing. Site contracts teams verify that HIPAA authorizations, insurance coverage, and local IRB requirements are incorporated to protect patients and institutional interests.

Security and Compliance Controls to Expect

Encryption: AES-256 at rest; TLS 1.2/1.3.

Audit Trail: Detailed timestamps, IP, action log.

HIPAA BAA: Business Associate Agreement required.

Access Controls: Role-based access and logs.

Authentication: Email, SMS code, or MFA.

Retention: Secure archival, tamper-evident storage.

Key Risks and Potential Consequences

HIPAA Penalties: Civil fines; corrective action.

Contract Disputes: Payment delays, indemnity claims.

Regulatory Delay: IRB hold or FDA audit.

Invalid Signatures: Unenforceable obligations.

Privacy Breach: State fines; reputational harm.

Tax Withholding: Incorrect 1099 triggers penalties.

Common Preparation Mistakes to Avoid

Incomplete HIPAA authorization forms or missing patient consent language can invalidate data sharing provisions and expose parties to civil penalties under HIPAA and state privacy laws.
Using inconsistent legal entity names or abbreviations between schedules, signature blocks, and invoices creates ambiguity and may void payment or indemnity clauses during enforcement.
Omitting clear payment schedules, milestones, or invoicing instructions often leads to late payments, disputes, and administrative holds that delay study activities and subject visits.
Failing to record effective dates, execution order, or authorized signers can make the agreement unenforceable or require costly amendments and re-signing.

Practical Examples of CTA Execution

Real-world examples show how e-signatures and structured CTAs speed execution while maintaining compliance for healthcare providers and research organizations.

Fertility Centers of Illinois

Fertility Centers of Illinois standardized clinical agreements and e-signature workflows to streamline patient authorizations and operational approvals across sites.

John Butler praised the API and responsiveness.
By centralizing templates and consent language, the center reduced signature turnaround and ensured consistent HIPAA addenda across locations, simplifying audits and reducing manual follow-up for missing authorizations.

Optica Ventures LLC

A small research sponsor simplified external consent routing using electronic templates and reduced turnaround times for investigator signatures.

Brian Fitzgibbons noted the interface simplicity.
Standard templates and audit trails improved sponsor oversight, reduced back-and-forth with sites, and provided timestamped records that supported compliance review and finance reconciliation during grant reporting.

Step-by-Step: Complete a Healthcare CTA Agreement

Follow these sequential steps to complete a Healthcare CTA Agreement accurately, from document preparation through execution and secure retention.

01

Prepare Parties: List full legal names and roles.
02

Define Scope: Summarize study purpose, procedures, and deliverables.
03

Set Payments: Specify milestones, invoicing, and tax responsibilities.
04

Sign & Archive: Add signatures, dates, and store securely.

How eSigning a CTA Typically Works

Typical eSignature flow for a Healthcare CTA Agreement proceeds from upload to completion, preserving an audit trail for compliance.

Upload Document: Attach final executed CTA and exhibits.
Place Fields: Add signature, date, and initials fields.
Authenticate Signer: Use email or SMS code verification.
Complete: Signed copies and certificate distributed automatically.

Core Sections to Include in a Professional CTA

A professional Healthcare CTA Agreement should explicitly cover clinical responsibilities, payment terms, data use, safety reporting, confidentiality, and termination to reduce disputes and ensure compliance.

Parties

Identify sponsor, CRO, investigative site, and any subcontractors with legal entity names, addresses, and authorized signers to prevent ambiguity during enforcement and invoicing.

Scope of Work

Detail the study protocol, subject population, enrollment targets, monitoring responsibilities, and deliverables so clinical and sponsor teams share operational expectations.

Budget & Payment

Specify amounts, milestones, allowable costs, invoicing procedures, tax treatment, and timelines for sponsor payments including remedies for late payment.

Indemnification

Define liability allocation, required insurance, patent and IP indemnities, and carve-outs for negligence or willful misconduct to protect institutional interests.

Data Use & Privacy

Address PHI handling, HIPAA authorizations, de-identification, data ownership, and permitted secondary uses; include security controls and retention rules under 45 CFR §164.530(j).

Termination

Describe termination for convenience, breach consequences, wind-down responsibilities, subject transition, and final accounting to reduce disruption at study closeout.

Recommended Digital Workflow Settings for CTAs

Configure your digital workflow to support CTA execution, conditional routing, and compliance controls for healthcare research environments.

Workflow Setting and Recommended Value	Authentication Method \| Field Types
Authentication Method	Email link, SMS code, or KBA.
Field Types	Signature, initials, date, and conditional fields.
Conditional Logic	Route based on role or funding source.
Bulk Send	Enable for multi-site investigator distribution.

Platform Capabilities to Check Before Signing

Ensure the signing platform supports integrations, secure formats, and authentication methods required for healthcare CTAs.

Integrations: Salesforce, NetSuite, Google Workspace.
Formats: PDF, DOCX, and HTML supported.
Authentication: MFA, SMS codes, KBA options.

Typical Timelines and Critical Deadlines

Key timing elements for Healthcare CTA Agreements focus on review cycles, IRB approvals, invoicing, and reporting obligations to align project schedules.

Sponsor Contractual Review and Approval Period:

Typically 14–30 calendar days for negotiation.

IRB Submission and Approval Timeline:

Commonly 30–60 days; varies by board.

Site Activation, Training, and Start-up:

Occurs after approvals; usually 7–21 days.

Invoicing Schedule and Payment Deadlines:

Net 30–60 days common; follow contract.

Safety Reporting, AE, and SAE Timelines:

Follow protocol and FDA reporting windows.

Milestone Sequence from Negotiation to Closeout

Major milestone sequence from negotiation through closeout highlights responsibilities and handoffs during a clinical trial.

01

Negotiation & Drafting

Agree on scope, budget, and IP terms.

02

IRB & Regulatory Approval

Secure IRB approval and any agency clearances.

03

Enrollment & Conduct

Execute study activities, collect data, and monitor safety.

04

Closeout & Archival

Final reports, data transfer, and records retention.

eSignature Vendor Pricing and Compliance Snapshot

The table compares starting price and compliance features for common eSignature vendors used to execute Healthcare CTA Agreements; signNow appears first.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

FAQs and Troubleshooting for Healthcare CTAs

Common questions about validity, compliance, signing authority, and storage for Healthcare CTA Agreements are answered below to reduce execution errors.

Need help? Contact support

Are e-signatures legally valid?
Yes. Electronic signatures that meet intent, consent, attribution, and record retention standards are legally enforceable under the ESIGN Act (15 U.S.C. §7001) and under UETA where adopted; certain exceptions such as wills and court filings remain ineligible.
How do I ensure HIPAA compliance?
Include explicit HIPAA authorization language, execute a Business Associate Agreement when a vendor will handle PHI, ensure encryption in transit and at rest (TLS 1.2/1.3, AES-256), and retain authorizations for six years per 45 CFR §164.530(j).
What level of signer authentication is sufficient?
Authentication depends on risk: email-only may suffice for low-risk approvals, while SMS, KBA, or multifactor authentication is recommended for PHI or regulated records. Stronger authentication improves attribution and auditability during disputes.
Is notarization required for CTAs?
Most CTAs do not require notarization, but institution policies or state law may require notarized signatures for specific exhibits or power-of-attorney documents. Use Remote Online Notarization where permitted and retain notarization records.
How do I amend an executed CTA?
Execute a written amendment that references the original agreement, have authorized signers sign and date the amendment, and retain it with the original CTA. Clearly state effective dates and any retroactive effects on reporting or payments.
How long should I keep signed CTAs?
Follow federal and industry retention rules: retain financial/tax records at least three years (IRC §6501(a)), HIPAA-related records six years (45 CFR §164.530(j)), and longer where state law or funder requirements apply.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now